NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/05/2023
Back to search
Official data from USPTO
GAMLEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/05/2023
Trademark type
Word
Nice classes
7, 9
Filing date
10/08/2012
Registration date
06/25/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2023
Last transaction
09/05/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/23/2011
First use in commerce
01/17/2012
Drawing code
4
Owner type
03
Owner location
Nottingham, GB
Examiner
OH, WON TEAK
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
Gamlen Tableting Limited
Representatives
Gloria Tsui-Yip Gottlieb, Rackman & Reisman, P.C.
Technical classification
Nice Classes
Class 7Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 7
Machines and machine toolsmachines for the production of pharmaceuticals in tablet form and machine tools for pharmaceutical tablet pressing; machines for the compressing of small volumes of tablets of pre-measured pharmaceutically active and inactive ingredients into tablet form; machines for the compressing of small volumes of tablets of pharmaceutically active and inactive ingredients into tablet form to assist in pharmaceutical research and development
Class 9
Scientificweighingmeasuringsignalling apparatus and instrumentscomputerized controls for the operation of machines for the production of pharmaceuticals in tablet form; computer hardware; computer firmware and computer software for control of machines for the production of pharmaceuticals in tablet form; furniture adapted for laboratory use; scientific equipmentapparatus for the compressibility testing and evaluation of pharmaceutical ingredients resulting in the production of pharmaceuticals in tablet form
Publications
History of USPTO decisions and trademark events.
28 publications found
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
09/05/2023
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
09/05/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/05/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/21/2023
E15R
TEAS SECTION 15 RECEIVED
06/27/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
06/09/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/25/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/02/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/02/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/02/2019
ES8R
TEAS SECTION 8 RECEIVED
06/23/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/25/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2013
PUBO
PUBLISHED FOR OPPOSITION
04/09/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/05/2013
ALIE
ASSIGNED TO LIE
03/05/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
02/07/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/07/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
02/07/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/07/2013
DOCK
ASSIGNED TO EXAMINER
02/05/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2012
NWAP
NEW APPLICATION ENTERED
10/11/2012
Continuous trademark protection
Get notified about every new filing that threatens GAMLEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.